Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Introduction Pancreatic ductal adenocarcinoma (PDA), or pancreatic cancer, is a devastating exogenous pancreatic disease that ranks the fourth leading cause of cancer mortality and is projected to be the second leading cause of death by 2030 in the United States (Rahib et al., 2014
Preliminary program results are promising: ~1,500 clients have enrolled in the program since the program launched in April 2023, including: 61% of commercial employer-sponsored lives 17% of commercial health plan lives ** 67% of members meet smart logic criteria and do not require submission of a PA request 84% of PA requests result in denial, and 72% overall target fill rate *** ~$1B or ~$4.86 PMPM in client savings 3 These drugs are being studied in both weight- and non-weight-related conditions
"I don't think it's fair, and I don't think it's right." But, legally speaking, affordability is not a gap that compounding pharmacies are supposed to fill
These issues are typically linked to indirect effects such as gastrointestinal symptoms, altered eating patterns, or nocturnal hypoglycaemia rather than a direct pharmacological action
She avoids eating out and prefers meals cooked by her personal chef
When you treat your body like a well-oiled machine, you'll get results
